News

Vertex Pharmaceuticals (NASDAQ: VRTX) has made it to the major leagues in the world of biotech. The company is the leading maker of cystic fibrosis (CF) treatments, with its products generating more

In this podcast, Motley Fool analyst Asit Sharma and host Ricky Mulvey discuss stress in the commercial real estate market, Delta's quarter, and Tesla's 50% run-up over the last month.

Then, we play

Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash

Any stock can have an impressive run, especially when broader equities are experiencing a bull market. Significantly fewer stocks can perform well through good and not-so-good times and deliver

Growth stocks aren't created equal, but great businesses can stand the test of time in a portfolio and reward shareholders many times over through the years. Healthcare stocks with strong business

Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive

The broader stock market benchmarks keep reaching new heights, but the S&P 500 index's ongoing bull run has been driven heavily by its largest components. That means there are still plenty of

What a difference a year makes for telecom giant AT&T (NYSE: T). Its stock price rose in recent months, reaching a 52-week high of $19.32 on July 1.

The stock's surge is a reversal from last July's

Few pharmaceutical companies are more prominent than Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY). However, their popularity relative to most of their peers hasn't helped them much in the

Viking Therapeutics (NASDAQ: VKTX) has been one of the hottest healthcare stocks to own this year, thanks to hype and excitement relating to its promising weight loss treatment, VK2735. The

Shares of Lantheus Holdings (NASDAQ: LNTH) were skyrocketing on Wednesday, up 34% as of 11:20 a.m. ET. The big gain came after the Centers for Medicare and Medicaid Services (CMS) released a

Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) are a pair of biotechs planning to follow in the footsteps of Novo Nordisk and Eli Lilly and develop GLP-1-targeted medicines for

Intellia Therapeutics (NASDAQ: NTLA) just published some new data that suggests the company has what it takes to continue being a leader in the gene editing space. While there's still a lot of work

This has been an amazing year for stocks, with a 12.6% rise in the benchmark S&P 500 index. Fortunately for us value-conscious investors, the latest bull run has been mostly constrained to a handful

Pfizer (NYSE: PFE) may not be the must-have pharmaceutical investment it was at one point. If your priority is reliable divided income, however, the drugmaker remains a rock-solid pick. Not only has

July is for barbecues, fireworks, and vacations. Many people don't want to think too hard about anything. Three Fool.com contributors think they have solutions for those investors who don't want to

Dividend stocks pay you regularly regardless of how the share price fluctuates. Ideally, of course, the share price will move steadily higher over time and make you money in two ways.

The good news

Billionaire investors don't necessarily need quarterly payments from dividend stocks to cover their day-to-day expenses, but they buy them anyway. That's because businesses that distribute a portion

The past few years have been tough ones for investors holding shares of Pfizer (NYSE: PFE). The Big Pharma stock is down by more than half from the peak it set in late 2021.

Pfizer's stock price was

On June 20, the Food and Drug Administration (FDA) gave Sarepta Therapeutics (NASDAQ: SRPT) exactly what it wanted. The agency upgraded the status of its gene therapy for Duchenne muscular dystrophy

The benchmark S&P 500 index keeps breaking new records thanks in large part to a handful of stocks at the top. Luckily for income-seeking investors, there are some highly reliable dividend stocks